157 related articles for article (PubMed ID: 16421754)
21. 5-Fluorouracil-related severe toxicity: a comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency.
Boisdron-Celle M; Remaud G; Traore S; Poirier AL; Gamelin L; Morel A; Gamelin E
Cancer Lett; 2007 May; 249(2):271-82. PubMed ID: 17064846
[TBL] [Abstract][Full Text] [Related]
22. Population study of dihydropyrimidine dehydrogenase in cancer patients.
Etienne MC; Lagrange JL; Dassonville O; Fleming R; Thyss A; Renée N; Schneider M; Demard F; Milano G
J Clin Oncol; 1994 Nov; 12(11):2248-53. PubMed ID: 7964939
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenetic and clinical aspects of dihydropyrimidine dehydrogenase deficiency.
van Kuilenburg AB; De Abreu RA; van Gennip AH
Ann Clin Biochem; 2003 Jan; 40(Pt 1):41-5. PubMed ID: 12542909
[TBL] [Abstract][Full Text] [Related]
24. [A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
Hashimoto T; Arai K; Iwasaki Y; Saze Z; Takahashi K; Yamaguchi T; Matsumoto H; Yasutome M; Hiruma K; Yamashita Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):985-8. PubMed ID: 16835493
[TBL] [Abstract][Full Text] [Related]
25. [Dihydropyrimidine deshydrogenase (DPD): rhythm and consequences].
Barrat-Petit MA; Naulin-Ifi C; Mahler P; Milano G
Pathol Biol (Paris); 2005 Jun; 53(5):261-4. PubMed ID: 15939134
[TBL] [Abstract][Full Text] [Related]
26. Is capecitabine safe in patients with gastrointestinal cancer and dihydropyrimidine dehydrogenase deficiency?
Saif MW; Diasio R
Clin Colorectal Cancer; 2006 Jan; 5(5):359-62. PubMed ID: 16512996
[TBL] [Abstract][Full Text] [Related]
27. Profound dihydropyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotype.
Johnson MR; Wang K; Diasio RB
Clin Cancer Res; 2002 Mar; 8(3):768-74. PubMed ID: 11895907
[TBL] [Abstract][Full Text] [Related]
28. Multiple organ failure due to 5-fluorouracil chemotherapy in a patient with a rare dihydropyrimidine dehydrogenase gene variant.
Lazar A; Mau-Holzmann UA; Kolb H; Reichenmiller HE; Riess O; Schömig E
Onkologie; 2004 Dec; 27(6):559-62. PubMed ID: 15591715
[TBL] [Abstract][Full Text] [Related]
29. Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency.
Takimoto CH; Lu ZH; Zhang R; Liang MD; Larson LV; Cantilena LR; Grem JL; Allegra CJ; Diasio RB; Chu E
Clin Cancer Res; 1996 Mar; 2(3):477-81. PubMed ID: 9816193
[TBL] [Abstract][Full Text] [Related]
30. Role of dihydropyrimidine dehydrogenase activity in patients with esophageal cancer.
Saeki H; Ito S; Futatsugi M; Kimura Y; Ohga T; Sugimachi K
Anticancer Res; 2002; 22(6B):3789-92. PubMed ID: 12552994
[TBL] [Abstract][Full Text] [Related]
31. Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians.
Mattison LK; Fourie J; Desmond RA; Modak A; Saif MW; Diasio RB
Clin Cancer Res; 2006 Sep; 12(18):5491-5. PubMed ID: 17000684
[TBL] [Abstract][Full Text] [Related]
32. The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster.
Yan J; Tyring SK; McCrary MM; Lee PC; Haworth S; Raymond R; Olsen SJ; Diasio RB
Clin Pharmacol Ther; 1997 May; 61(5):563-73. PubMed ID: 9164418
[TBL] [Abstract][Full Text] [Related]
33. A neonate with recurrent vomiting and generalized hypotonia diagnosed with a deficiency of dihydropyrimidine dehydrogenase.
Brussel W; van Kuilenburg AB; Janssens PM
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1099-102. PubMed ID: 17065071
[TBL] [Abstract][Full Text] [Related]
34. Dihydropyrimidine dehydrogenase pharmacogenetics in the Taiwanese population.
Hsiao HH; Yang MY; Chang JG; Liu YC; Liu TC; Chang CS; Chen TP; Lin SF
Cancer Chemother Pharmacol; 2004 May; 53(5):445-51. PubMed ID: 15132136
[TBL] [Abstract][Full Text] [Related]
35. (13)C-uracil breath test to predict 5-fluorouracil toxicity in gastrointestinal cancer patients.
Cunha-Junior GF; De Marco L; Bastos-Rodrigues L; Bolina MB; Martins FL; Pianetti GA; Cesar IC; Coelho LG
Cancer Chemother Pharmacol; 2013 Dec; 72(6):1273-82. PubMed ID: 24101147
[TBL] [Abstract][Full Text] [Related]
36. Plasma level of a 5-fluorouracil metabolite, fluoro-beta-alanine correlates with dihydropyrimidine dehydrogenase activity of peripheral blood mononuclear cells in 5-fluorouracil treated patients.
Furuhata T; Kawakami M; Okita K; Kimura Y; Kihara C; Tsuruma T; Ohmura T; Yamaguchi K; Hata F; Katsuramaki T; Sasaki K; Hirata K
J Exp Clin Cancer Res; 2006 Mar; 25(1):79-82. PubMed ID: 16761622
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylation of the DPYD promoter region is not a major predictor of severe toxicity in 5-fluorouracil based chemotherapy.
Amstutz U; Farese S; Aebi S; Largiadèr CR
J Exp Clin Cancer Res; 2008 Oct; 27(1):54. PubMed ID: 18937829
[TBL] [Abstract][Full Text] [Related]
38. Mutational spectrum of dihydropyrimidine dehydrogenase gene (DPYD) in the Tunisian population.
Ben Fredj R; Gross E; Chouchen L; B'Chir F; Ben Ahmed S; Neubauer S; Kiechle M; Saguem S
C R Biol; 2007 Oct; 330(10):764-9. PubMed ID: 17905396
[TBL] [Abstract][Full Text] [Related]
39. Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine.
Saif MW; Elfiky A; Diasio R
Clin Colorectal Cancer; 2006 Sep; 6(3):219-23. PubMed ID: 17026792
[TBL] [Abstract][Full Text] [Related]
40. The significance of the expression of dihydropyrimidine dehydrogenase in prostate cancer.
Li Y; Mizutani Y; Shiraishi T; Nakamura T; Mikami K; Takaha N; Okihara K; Kawauchi A; Sakai T; Miki T
BJU Int; 2007 Mar; 99(3):663-8. PubMed ID: 17092280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
